ACA
PACB icon

Atlas Capital Advisors’s Pacific Biosciences PACB Stock Holding History

Atlas Capital Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,019
Closed -$3.12K – 718
2020
Q1 		$3.12K Buy
+1,019
New +$4.17K ﹤0.01% 641
2019
Q4 		– Sell
-77,891
Closed -$402K – 659
2019
Q3 		$402K Buy
77,891
+4,996
+7% +$27.9K 0.12% 215
2019
Q2 		$441K Sell
72,895
-1,055
-1% -$7.4K 0.14% 184
2019
Q1 		$535K Hold
73,950
– – 0.19% 139
2018
Q4 		$547K Buy
+73,950
New +$469K 0.22% 122

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return